REALE, Marcella
 Distribuzione geografica
Continente #
NA - Nord America 7.822
EU - Europa 6.683
AS - Asia 4.920
SA - Sud America 462
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 5
Totale 19.951
Nazione #
US - Stati Uniti d'America 7.699
CN - Cina 1.854
SG - Singapore 1.664
IE - Irlanda 1.230
UA - Ucraina 1.166
IT - Italia 972
SE - Svezia 923
TR - Turchia 889
GB - Regno Unito 730
DE - Germania 485
FR - Francia 458
BR - Brasile 422
IN - India 313
FI - Finlandia 252
RU - Federazione Russa 200
CA - Canada 99
CZ - Repubblica Ceca 72
AT - Austria 61
HK - Hong Kong 45
VN - Vietnam 40
BE - Belgio 39
BD - Bangladesh 21
EU - Europa 19
NL - Olanda 16
KR - Corea 15
MX - Messico 15
PL - Polonia 13
AR - Argentina 11
IR - Iran 11
AE - Emirati Arabi Uniti 10
ES - Italia 10
CL - Cile 9
LT - Lituania 9
RO - Romania 9
ZA - Sudafrica 9
JP - Giappone 7
MA - Marocco 7
EC - Ecuador 6
EG - Egitto 6
ID - Indonesia 6
IL - Israele 6
PK - Pakistan 6
BG - Bulgaria 5
CH - Svizzera 5
TN - Tunisia 5
AL - Albania 4
IQ - Iraq 4
KE - Kenya 4
AU - Australia 3
AZ - Azerbaigian 3
CM - Camerun 3
CO - Colombia 3
DK - Danimarca 3
GR - Grecia 3
HU - Ungheria 3
NO - Norvegia 3
NP - Nepal 3
PT - Portogallo 3
PY - Paraguay 3
TW - Taiwan 3
AM - Armenia 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HR - Croazia 2
JM - Giamaica 2
NZ - Nuova Zelanda 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
RS - Serbia 2
SA - Arabia Saudita 2
TH - Thailandia 2
UZ - Uzbekistan 2
VE - Venezuela 2
AO - Angola 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CY - Cipro 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
IM - Isola di Man 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MM - Myanmar 1
MT - Malta 1
OM - Oman 1
PS - Palestinian Territory 1
SC - Seychelles 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 19.951
Città #
Chandler 1.402
Jacksonville 1.337
Dublin 1.223
Singapore 1.154
Princeton 511
Southend 505
Izmir 464
Shenzhen 450
Nanjing 390
The Dalles 274
Wilmington 266
Dearborn 258
Ashburn 255
Beijing 252
Chieti 234
Santa Clara 232
Cambridge 222
Ann Arbor 193
Altamura 158
Nanchang 140
Boardman 133
Woodbridge 123
Pescara 81
New York 80
Shenyang 76
Los Angeles 75
Munich 67
Washington 61
Hebei 60
Tianjin 59
Grevenbroich 57
Jiaxing 54
Kunming 50
São Paulo 49
Vienna 48
Hong Kong 44
Montréal 39
Dong Ket 38
Brno 37
Jinan 37
Norwalk 35
Brussels 34
Hangzhou 34
Helsinki 33
Houston 33
Olomouc 33
Changsha 29
Rome 28
Falls Church 27
Toronto 26
Mcallen 22
Ningbo 22
Zhengzhou 21
Seattle 19
Guangzhou 18
Orange 18
San Mateo 18
Turku 18
Auburn Hills 17
Augusta 17
Milan 17
Pune 17
Düsseldorf 16
Scottsdale 16
Brooklyn 15
Frankfurt am Main 14
London 14
Taizhou 13
Changchun 12
Lanciano 12
Lanzhou 12
Nuremberg 12
Chicago 11
Leawood 11
Shanghai 11
Belo Horizonte 10
Brasília 10
Fuzhou 10
Montreal 10
Tappahannock 10
Amsterdam 9
Ardabil 9
Boston 9
Dallas 9
Kocaeli 9
Moscow 9
Ottawa 9
Pianella 9
Rio de Janeiro 9
Turin 9
Bangalore 7
Campobasso 7
Espoo 7
Lappeenranta 7
San Francisco 7
Stockholm 7
Tokyo 7
Ancona 6
Dhaka 6
Dubai 6
Totale 12.100
Nome #
Neuronal cellular responses to extremely low frequency electromagnetic field exposure: implications regarding oxidative stress and neurodegeneration 533
Mast cell recruitment after subcutaneous injection of RANTES in the sole of the rat paw. 218
Development of glycine-α-methyl-proline-containing tripeptides with neuroprotective properties 151
Antiinflammatory effects in THP-1 cells treated with verbascoside 135
5-HT and histamine release from rat basophilic leukemia cells treated or non with IL-1RA 130
Work stress and innate immune response 128
Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: implication in peripheral inflammation 127
Alzheimer patients treated with an AchE inhibitor show higher IL-4 and lower IL-1β levels and expression in peripheral blood mononuclear cells 123
Effect of probiotic supplement on cytokine levels in HIV-infected individuals: A preliminary study 121
Effects of 50 Hz sinusoidal electromagnetic fields on MCP-1 and RANTES generated from activated human macrophages 121
Effect of MK-571, a selective leukotriene D4 receptor antagonist, on vascular smooth muscle cell proliferation and interleukin 1 release 120
Cholinergic Markers and Cytokines in OSA Patients 119
Saliva, an easily accessible fluid as diagnostic tool and potent stem cell source for Alzheimer’s Disease: present and future applications 116
Dysregulated homeostasis of acetylcholine levels in immune cells of RR-multiple sclerosis patients 115
NSAID Coniugates for the treatment of Alzheimer's Disease 115
Blood natural killer activity is reduced in men with occupational stress and job insecurity working in a university 114
Antiphospholipid Antibodies Overlapping in Isolated Neurological Syndrome and Multiple Sclerosis: Neurobiological Insights and Diagnostic Challenges 114
Cholinergic System Dysfunction in Multiple Sclerosis Patients 112
Follow up study on the immune response to low frequency electromagnetic fields in men and women working in a museum. 111
Augmentation of monocyte chemotactic protein-1 (MCP-1) and mRNA Transcript in chronic inflammatory states induced by potassium permanganate (KMnO4) in vivo 109
Activity of matrix metallo proteinases (MMPs) and the tissue inhibitorof MMP (TIMP)-1 in electromagnetic field-exposed THP-1 cells. 109
In vitro effects of nickel-sulphate on immune functions of normal and nickel-allergic subjects: a regulatory role for zinc. 109
Oxygen supply modulates MCP-1 release in monocytes from young and aged rats: decrease of MCP-1 transcription and translation is age-related 109
Synergistic activation of serum amyloid a (saa) by il - 6 and il - 1 in combination on human hep 3 b hepatoma cell line. Role of pge2 and il-1 receptor antagonist 108
Synthesis, biological evaluation and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase 108
Well-being at work and immune response 108
Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. 107
Synthesis and biological evaluation of novel analogues of Gly-l-Pro-l-Glu (GPE) as neuroprotective agents 107
Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls. 107
MicroRNA in Sjögren's syndrome: Their potential roles in pathogenesis and diagnosis 106
Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1beta and interleukin-6 release from lymphocytes of Alzheimer's disease patients 105
Effect of electromagnetic fields on several CD markers and transcription and expression of CD4 105
The immune response of women with prolonged exposure to electromagnetic fields produced by radiotelevision broadcasting stations. 104
Extremely low frequency electromagnetic field enhances human keratinocyte cell growth and decreases proinflammatory chemokine production 103
Increased expression of transforming growth factor beta isoforms by human monocytes of hypertensive patients 102
Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related 102
Extremely low-frequency electromagnetic fields accelerates wound healing modulating MMP-9 and inflammatory cytokines 101
Production of cytokines in trichinellosis infected mice 99
L-carnitine enhances adenosine triphosphate (ATP) and inhibits lymphocite proliferation 99
Monocyte chemotactic protein 1 (MCP-1) activates mast cells to aggregate and release [3H]-5HT 98
Effect of occupational stress and anxiety on natural killer lymphocyte activity of men and women employed in a university. 98
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 97
Anti-inflammatory properties of acetylcholinesterase inhibitors administred in Alzheimer's disease 97
Critical review on the presence of phthalates in food and evidence of their biological impact 97
Acetylcholine in multiple sclerosis: possible involvement in the modulation of the immune response and in oligodendrocyte recruitment. 96
Age-related Expression of Cholinergic Markers and Cytokines in the Olfactory Bulb of a Rat Model of Alzheimer’s Disease. 96
Circulating CD40 ligand, Dickkopf-1 and P-selectin in HIV-infected patients 96
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 96
Effects of palladium nanoparticles on the cytokine release from peripheral blood mononuclear cells of palladium-sensitized women 95
Human Gingival Fibroblasts Exposed to Extremely Low-Frequency Electromagnetic Fields: In Vitro Model of Wound-Healing Improvement 95
EMF Exposure Facilitates Wound Healing Events Modulating Cytokines Expression. 95
Human interleukin 1 receptor antagonist (IL-1RA) inhibition of inducible thromboxane B2 generation in human monocytes 95
RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b 93
Novel NSAID-derived drugs for the potential treatment of Alzheimer’s disease 93
Modulation of MCP-1 and iNOS by 50 Hz sinusoidal electromagnetic field 92
A pathophysiological role for selective alteration of the cytokine-chemokine network - inflammatory theory in Alzheimer's disease 92
Relationship between inflammatory mediators, Aβ levels and ApoE genotype in Alzheimer disease 92
Lipids at the Cross-Road of Autoimmunity in Multiple Sclerosis 92
In vitro effects of low frequency electromagnetic fields on Anti Microbial Peptides (AMP) expression 92
Interferon β1b modulates MCP-1 expression and production in relapsing-remitting multiple sclerosis 92
null 91
Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines. 91
Chemokine production by mononuclear cells from relapsing-remitting multiple sclerosis (RR-MS) patients 91
Monocyte Chemotactis Protein-1 Gene Expression and Translation in Formed Granulomatous Calcified Tissue in Vivo 91
"In vitro" effects of different arsenic compounds on PBMC (preliminary study). 90
Anti-inflammatory strategy: Old ally or new promise in therapy 90
Inhibitory effects of cadmium on peripheral blood mononuclear cell proliferation and cytokine release are reversed by zinc and selenium salts 90
Different effects of platinum, palladium, and rhodium salts on lymphocyte proliferation and cytokine release 89
The down-regulation of il-6-stimulated fibrinogen steadu state mrna and protein levels by human recombinant il-1 is not pge2-dependent:effects of il-1 receptor antagonist (il-1ra) 88
Rantes and MCP-1 Secretion by Mononuclear Cells of Patients with Nultiple Sclerosis 88
Extremely Low Frequency Electromagnetic Field and Cytokines Production. 88
Profiling of canonical and non-traditional cytokine levels in IFNbeta-treated RR-MS patients 88
In vitro effects of vanadate on human immune functions 88
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 87
Modulation of interleukin 18 by treatment with acetylcholinesterase inhibition in Alzheimer patients 87
Heat shock protein 70: implication for Alzheimer's disease 87
Transforming growth factor beta1 induces IL-1 receptor antagonist production and gene expression in rat vascular smooth muscle cells 87
Polymorphisms of chemokine receptor genes in Alzheimer's and Parkinson's Patients 87
Cytokines and T cells in atopic dermatitis. 87
Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect? 87
Human recombinant interleukin-1 receptor antagonist (hrIL-1RA) inhibits prostaglandin E2(PGE) generation but not alkaline phosphatase activity in in vivo chronic granulomatous tissue induced by KMnO4 86
The acetylcholinesterase inhibitor, Donepezil, regulates a Th2 bias in Alzheimer’s disease patients. 86
Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. 86
Alzheimer’s Disease And Type 2 Diabetes: Exploring The Association To Obesity And Tyrosine Hydroxylase 86
Nicotinic receptor activation negatively modulates pro-inflammatory cytokine production in multiple sclerosis patients 86
Job strain in different types of employment affects the immune response 86
Selective acetyl- and butyrylcholinesterase inhibitors reduce amyloid-β ex vivo activation of peripheral chemo-cytokines from Alzheimer's disease subjects: exploring the cholinergic anti-inflammatory pathway 86
Transforming growth factor beta1 induces IL-1 receptor antagonist gene expression and production in rat vascular smooth muscle cells 85
Will MCP-1 and RANTES take center stage in inflammatory diseases including asthma? 85
Aumentati livelli mucosali gastrici di IL-1alfa, IL-6 ed IL-8 in pazienti Helicobacter pylori-positivi affetti da cardiopatia ischemica. 85
Cytokine Levels and UVr Sensitivity in HaCaT Cells and Cetuximab Treated Patients. 85
Alzheimer's Disease and Type 2 Diabetes Mellitus: The Link to Tyrosine Hydroxylase and Probable Nutritional Strategies 85
Vitamin B6-deficient diet plus 4-deoxypyridoxine (4-DPD) reduces the inflammatory response induced by T. spiralis in diaphragm, masseter and heart muscle tissue of mice 84
INCREASED ADIPOKINES LEVELS IN NORMAL-WEIGHT MULTIPLE SCLEROSIS PATIENTS 84
Effect of interleukin-1 receptor antagonist (IL-1RA) on histamine and serotonin release by rat basophilic leukemia cells (RBL-2H3) and peritoneal mast cells 83
Kinetic Study on the Effects of Extremely Low Frequency Electromagnetic Field on Catalase, Cytochrome P450 and Inducible Nitric Oxide Synthase in Human HaCaT and THP-1 Cell Lines. 83
Extremely low frequency Electromagnetic fields (ELF-EMF) effect on morphology and geneticexpression profile of a human keratinocyte line (HaCaT) 83
Differential expression and secretion of RANTES and MCP-1 in activated peripheral blood mononuclear cell cultures of atopic subjects. 83
Network between cytokines, cortisol and occupational stress in gas and oilfield workers 83
MCP-1 and MIP-2 expression and production in BB diabetic rat: Effect of chronic hypoxia 83
Totale 10.384
Categoria #
all - tutte 87.173
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.173


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202077 0 0 0 0 0 0 0 0 0 0 0 77
2020/20211.687 238 40 265 12 112 338 26 27 200 200 86 143
2021/20221.176 62 14 14 222 72 32 43 93 88 34 134 368
2022/20233.810 296 454 220 447 379 771 227 300 487 63 96 70
2023/20242.282 104 68 582 60 110 518 477 62 18 31 29 223
2024/20254.188 319 855 802 96 131 167 131 233 485 220 585 164
Totale 21.074